- Home
- LINE vs BMRN Comparison
LINE vs BMRN Comparison
Compare LINE & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LINE
- BMRN
- Stock Information
- Founded
- LINE 2012
- BMRN 1996
- Country
- LINE United States
- BMRN United States
- Employees
- LINE N/A
- BMRN N/A
- Industry
- LINE
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- LINE
- BMRN Health Care
- Exchange
- LINE NYSE
- BMRN Nasdaq
- Market Cap
- LINE 9.8B
- BMRN 11.3B
- IPO Year
- LINE 2024
- BMRN 1999
- Fundamental
- Price
- LINE $42.35
- BMRN $58.14
- Analyst Decision
- LINE Buy
- BMRN Buy
- Analyst Count
- LINE 18
- BMRN 23
- Target Price
- LINE $66.11
- BMRN $93.73
- AVG Volume (30 Days)
- LINE 971.4K
- BMRN 1.8M
- Earning Date
- LINE 08-06-2025
- BMRN 08-04-2025
- Dividend Yield
- LINE 4.98%
- BMRN N/A
- EPS Growth
- LINE N/A
- BMRN 152.82
- EPS
- LINE N/A
- BMRN 2.71
- Revenue
- LINE $5,302,000,000.00
- BMRN $2,950,227,000.00
- Revenue This Year
- LINE $3.58
- BMRN $12.27
- Revenue Next Year
- LINE $4.95
- BMRN $9.99
- P/E Ratio
- LINE N/A
- BMRN $21.50
- Revenue Growth
- LINE N/A
- BMRN 19.36
- 52 Week Low
- LINE $40.49
- BMRN $52.93
- 52 Week High
- LINE $88.78
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- LINE N/A
- BMRN 51.02
- Support Level
- LINE N/A
- BMRN $57.58
- Resistance Level
- LINE N/A
- BMRN $59.62
- Average True Range (ATR)
- LINE 0.00
- BMRN 1.49
- MACD
- LINE 0.00
- BMRN -0.05
- Stochastic Oscillator
- LINE 0.00
- BMRN 42.03
About LINE LINEAGE INC
Lineage Inc is a temperature-controlled warehouse real estate investment trust. It operates an interconnected global temperature-controlled warehouse network, comprising approximately millions of square feet across several warehouses predominantly located in densely populated critical-distribution markets across North America, Asia-Pacific, and Europe. The company's reportable segments are Global Warehousing, which utilizes the company's industrial real estate properties to provide temperature-controlled warehousing services to its customers, and Global Integrated Solutions, which complements Global Warehousing with specialized cold-chain services. Maximum revenue is generated from the Global Warehousing segment. Geographically, the company derives its key revenue from the United States.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.